instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'NITAZOXANIDE'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, DOSE INCREASED | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the dosage of drug 'ZIDOVUDINE'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | UNK, SECOND-LINE THERAPY | DrugDosageText | CC BY-NC | 33732476 | 19,903,764 | 2021-03 |
What was the outcome of reaction 'Blood electrolytes abnormal'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Cachexia'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Condition aggravated'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Cryptosporidiosis infection'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Cytomegalovirus oesophagitis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Dehydration'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Erythema'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Ichthyosis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Oesophageal candidiasis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Oral candidiasis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Oral mucosal erythema'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Punctate keratitis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'SJS-TEN overlap'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Skin lesion'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 19,889,986 | 2021-03 |
What was the outcome of reaction 'Stevens-Johnson syndrome'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 20,020,604 | 2021-03 |
What was the outcome of reaction 'Toxic epidermal necrolysis'? | Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient.
We report a case of advanced human immunodeficiency virus (HIV) infection with multiple opportunistic infections (Pneumocystis carinii pneumonia, cryptosporidiosis, oesophagal candidiasis and cytom... | Recovered | ReactionOutcome | CC BY-NC | 33732476 | 20,020,604 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
What was the outcome of reaction 'Cardiogenic shock'? | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | Fatal | ReactionOutcome | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
What was the outcome of reaction 'Off label use'? | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | Fatal | ReactionOutcome | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
What was the outcome of reaction 'Septic shock'? | Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy.
Insight into predictors of cardiac involvement in inflammatory myopathies is sparse. A negative prognostic role of anti-mitochondrial antibodies (AMA) has been noticed and is supported by the current case. We describe a male patient who at ... | Fatal | ReactionOutcome | CC BY-NC | 33732479 | 20,074,331 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Low birth weight baby'. | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732483 | 19,971,945 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Narcotic bowel syndrome'. | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732483 | 19,374,172 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neonatal respiratory distress'. | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | CANNABIS SATIVA SUBSP. INDICA TOP, METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732483 | 19,903,447 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory distress'. | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | METHADONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732483 | 19,374,172 | 2021-03 |
What was the administration route of drug 'CANNABIS SATIVA SUBSP. INDICA TOP'? | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | Transplacental | DrugAdministrationRoute | CC BY | 33732483 | 19,903,447 | 2021-03 |
What was the administration route of drug 'METHADONE HYDROCHLORIDE'? | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | Transplacental | DrugAdministrationRoute | CC BY | 33732483 | 19,903,447 | 2021-03 |
What was the outcome of reaction 'Narcotic bowel syndrome'? | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | Recovered | ReactionOutcome | CC BY | 33732483 | 19,374,172 | 2021-03 |
What was the outcome of reaction 'Respiratory distress'? | Paralytic ileus in the neonate as a rare complication of maternal methadone treatment-a case report.
Narcotic bowel syndrome is defined as worsening abdominal bloating and cramping with chronic opiate use, leading to paralytic ileus. This syndrome is common yet underreported in adults. However, there is no current evid... | Recovered | ReactionOutcome | CC BY | 33732483 | 19,374,172 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactate dehydrogenase increased'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dermatitis acneiform'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ejection fraction decreased'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant melanoma'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, DOXYCYCLINE, MINOCYCLINE HYDROCHLORIDE, PREDNISOLONE, RIBOCICLIB, TETRACYCLINE | DrugsGivenReaction | CC BY | 33732653 | 20,162,185 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, DOXYCYCLINE, MINOCYCLINE HYDROCHLORIDE, PREDNISOLONE, RIBOCICLIB, TETRACYCLINE | DrugsGivenReaction | CC BY | 33732653 | 20,162,185 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Protein S increased'. | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | BINIMETINIB, RIBOCICLIB | DrugsGivenReaction | CC BY | 33732653 | 20,877,777 | 2021 |
What was the administration route of drug 'DOXYCYCLINE'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Oral | DrugAdministrationRoute | CC BY | 33732653 | 20,162,185 | 2021 |
What was the administration route of drug 'MINOCYCLINE HYDROCHLORIDE'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Oral | DrugAdministrationRoute | CC BY | 33732653 | 20,162,185 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33732653 | 20,162,185 | 2021 |
What was the administration route of drug 'TETRACYCLINE'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Oral | DrugAdministrationRoute | CC BY | 33732653 | 20,162,185 | 2021 |
What was the outcome of reaction 'Dermatitis acneiform'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Recovered | ReactionOutcome | CC BY | 33732653 | 20,877,777 | 2021 |
What was the outcome of reaction 'Ejection fraction decreased'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Recovered | ReactionOutcome | CC BY | 33732653 | 20,877,777 | 2021 |
What was the outcome of reaction 'Pneumonitis'? | Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma.
There are only limited treatment options for metastatic NRAS mutant melanoma patients with resistance to immune checkpoint inhibitors. Besides activation of the mitogen-activated protein (MAP) kinase pathway, they often have ... | Recovered | ReactionOutcome | CC BY | 33732653 | 20,877,777 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure acute'. | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | BUSULFAN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, IDARUBICIN, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, MERCAPTOPURINE, METHOTREXATE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732669 | 19,095,975 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | BUSULFAN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, IDARUBICIN, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, MERCAPTOPURINE, METHOTREXATE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732669 | 19,095,975 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxic cardiomyopathy'. | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | BUSULFAN, CYCLOPHOSPHAMIDE, CYTARABINE, ETOPOSIDE, IDARUBICIN, LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN, MERCAPTOPURINE, METHOTREXATE, MITOXANTRONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33732669 | 19,095,975 | 2021 |
What was the dosage of drug 'BUSULFAN'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | 3.2 MG/KG | DrugDosageText | CC BY | 33732669 | 19,095,975 | 2021 |
What was the dosage of drug 'IDARUBICIN'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | UNK (CUMULATIVE DOSE OF 189 MG/M2) | DrugDosageText | CC BY | 33732669 | 19,095,975 | 2021 |
What was the dosage of drug 'LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | 6 MG/KG | DrugDosageText | CC BY | 33732669 | 19,095,975 | 2021 |
What was the dosage of drug 'MITOXANTRONE HYDROCHLORIDE'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | 162 MG/M2 | DrugDosageText | CC BY | 33732669 | 19,095,975 | 2021 |
What was the outcome of reaction 'Cardiac failure acute'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | Recovered | ReactionOutcome | CC BY | 33732669 | 19,095,975 | 2021 |
What was the outcome of reaction 'Toxic cardiomyopathy'? | Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy.
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. Howe... | Recovered | ReactionOutcome | CC BY | 33732669 | 19,095,975 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | CISPLATIN, FUROSEMIDE, MANNITOL | DrugsGivenReaction | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | CISPLATIN, FUROSEMIDE, MANNITOL | DrugsGivenReaction | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the administration route of drug 'CISPLATIN'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | Intraperitoneal | DrugAdministrationRoute | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the administration route of drug 'FUROSEMIDE'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the administration route of drug 'MANNITOL'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the dosage of drug 'CISPLATIN'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | INFUSION; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY | DrugDosageText | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the dosage of drug 'FUROSEMIDE'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | APPROXIMATELY 60 MIN PRIOR TO INFUSION OF CISPLATIN | DrugDosageText | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the dosage of drug 'MANNITOL'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | APPROXIMATELY 60 MIN PRIOR TO INFUSION OF CISPLATIN INTRAPERITONEALLY, THE PATIENT RECEIVED 30 G ... | DrugDosageText | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the outcome of reaction 'Acute kidney injury'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | Recovering | ReactionOutcome | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
What was the outcome of reaction 'Nephropathy toxic'? | Sodium thiosulfate for postoperative cisplatin induced nephrotoxicity following hyperthermic intraperitoneal chemotherapy: A case report.
•Cisplatin induced nephrotoxicity can occur days after administration.•Hyperthermic intraperitoneal chemotherapy with cisplatin for ovarian cancer is increasing in utilization.•Sodiu... | Recovering | ReactionOutcome | CC BY-NC-ND | 33732850 | 19,132,286 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestine perforation'. | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | HYDROCORTISONE, INFLIXIMAB, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | HYDROCORTISONE, INFLIXIMAB, METRONIDAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
What was the administration route of drug 'HYDROCORTISONE'? | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
What was the dosage of drug 'HYDROCORTISONE'? | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
What was the dosage of drug 'METRONIDAZOLE'? | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
What was the outcome of reaction 'Large intestine perforation'? | Amoebic colitis: A case series of a recurring missed diagnosis.
Entamoeba histolytica, a pathogenic protozoan that causes amoebiasis, remains the second leading cause of death from parasitic infections worldwide. We present a case series of patients presenting to metropolitan tertiary gastroenterology units in Melbourn... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732890 | 18,712,261 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Conjunctival oedema'. | Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report.
To describe a case of massive spontaneous subconjunctival hemorrhage in a patient taking warfarin with a therapeutic international normalized ratio (INR).
Massive circumferential hemorrhagic chemosis, extensive periorbit... | ASPIRIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33732947 | 19,443,961 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report.
To describe a case of massive spontaneous subconjunctival hemorrhage in a patient taking warfarin with a therapeutic international normalized ratio (INR).
Massive circumferential hemorrhagic chemosis, extensive periorbit... | ASPIRIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33732947 | 19,443,961 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Periorbital haematoma'. | Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report.
To describe a case of massive spontaneous subconjunctival hemorrhage in a patient taking warfarin with a therapeutic international normalized ratio (INR).
Massive circumferential hemorrhagic chemosis, extensive periorbit... | ASPIRIN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33732947 | 19,443,961 | 2021-06 |
What was the dosage of drug 'WARFARIN SODIUM'? | Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report.
To describe a case of massive spontaneous subconjunctival hemorrhage in a patient taking warfarin with a therapeutic international normalized ratio (INR).
Massive circumferential hemorrhagic chemosis, extensive periorbit... | 2.5 MG DAILY WITH TWO DAYS OF 3.75 MG | DrugDosageText | CC BY-NC-ND | 33732947 | 19,061,275 | 2021-06 |
What was the outcome of reaction 'Conjunctival haemorrhage'? | Massive spontaneous subconjunctival hemorrhage in a patient on therapeutic warfarin: A case report.
To describe a case of massive spontaneous subconjunctival hemorrhage in a patient taking warfarin with a therapeutic international normalized ratio (INR).
Massive circumferential hemorrhagic chemosis, extensive periorbit... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732947 | 19,061,275 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus chorioretinitis'. | Cytomegalovirus retinitis following dexamethasone intravitreal implant.
To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII).
Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in h... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 33732951 | 19,069,371 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cytomegalovirus retinitis following dexamethasone intravitreal implant.
To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII).
Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in h... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 33732951 | 19,069,371 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Uveitis'. | Cytomegalovirus retinitis following dexamethasone intravitreal implant.
To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII).
Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in h... | DEXAMETHASONE | DrugsGivenReaction | CC BY-NC-ND | 33732951 | 19,069,371 | 2021-06 |
What was the administration route of drug 'DEXAMETHASONE'? | Cytomegalovirus retinitis following dexamethasone intravitreal implant.
To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII).
Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in h... | Intraocular | DrugAdministrationRoute | CC BY-NC-ND | 33732951 | 19,069,371 | 2021-06 |
What was the outcome of reaction 'Cytomegalovirus chorioretinitis'? | Cytomegalovirus retinitis following dexamethasone intravitreal implant.
To describe a case of Cytomegalovirus (CMV) Retinitis in an immunocompetent patient following Dexamethasone Intravitreal Implant (DII).
Retrospective chart review of a single patient. An 80-year-old immunocompetent male presented with floaters in h... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732951 | 19,069,371 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | ADALIMUMAB, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vitritis'. | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | ADALIMUMAB, METHOTREXATE, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
What was the administration route of drug 'ADALIMUMAB'? | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
What was the administration route of drug 'PREDNISONE'? | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
What was the dosage of drug 'ADALIMUMAB'? | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | 40 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
What was the outcome of reaction 'Drug ineffective'? | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
What was the outcome of reaction 'Vitritis'? | Chronic endophthalmitis from Aquamicrobium lusatiense.
To report a case of chronic endophthalmitis caused by Aquamicrobium lusatiense following phacoemulsification surgery.
A 71 year-old woman was referred for chronic ocular inflammation after cataract surgery. Serologic testing was negative for common infectious etiol... | Recovered | ReactionOutcome | CC BY-NC-ND | 33732953 | 19,407,694 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,323,988 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Glomerulonephritis acute'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,376,834 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Granuloma'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,323,988 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Medication error'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,376,834 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product administration error'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,323,988 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product prescribing error'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,323,988 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33733898 | 19,280,096 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | AMANTADINE HYDROCHLORIDE, NITROFURANTOIN | DrugsGivenReaction | CC BY-NC | 33733898 | 19,097,961 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.